Venture Capital Investors

Dementia Discovery Fund

Dementia Discovery Fund is a venture capital investment firm that backs tech companies.

Venture Investor Overview

Contact Information

Background Information

Overview

The Dementia Discovery Fund (DDF) is an innovative global investment fund established in October 2015 to deliver new disease modifying drugs for dementia by 2025. Managed by SV Life Sciences Managers LLP, the DDF investors include the UK Government's Department of Health, Alzheimer's Research UK and world-leading major pharmaceutical companies: Biogen, GlaxoSmithKline, Johnson & Johnson, Lilly, Pfizer and Takeda.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

2/13/2024

Transaction History

Our records indicate that Dementia Discovery Fund invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

No employees have been recorded for this company.

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Dementia Discovery Fund has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Demcon Investment | Demeter Capital

Share this article

About Our VC Firm Database

The venture capital investor data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary